US Federal Trade Commission Sues CVS Health, Cigna, UnitedHealth's Pharmacy Benefit Managers For Inflating Insulin Prices
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers (PBMs)—CVS Health Inc’s (NYSE:CVS) Caremark, Cigna Corp’s (NYSE:CI) Express Scripts,
The Times wants to hear from patients and providers about medical practices affiliated with Optum, a subsidiary of UnitedHealth Group. Share your experience below. By Chris Hamby Several ...
Zacks.com on MSN1d
UnitedHealth at 19.09X P/E: Worth the Price or Time to Take Profits?UnitedHealth Group Incorporated UNH is currently viewed as expensive, with the stock trading at a 19.09X forward 12-month ...
PBMs, like Optum Rx, are the key counterweight to pharmaceutical companies’ otherwise unchecked monopoly power to set and raise drug prices.
UnitedHealth's aggressive M&A strategy and focus on data analytics drive growth and margin improvements, justifying a 'Strong ...
UnitedHealth Group's Optum Rx will join its peers in the big three pharmacy benefit managers by pulling Humira from some of ...
About 50 people gathered in Eden Prairie to allege biggest players in industry are ballooning drug costs while running ...
The majority of cuts will take place in December, according to a notice filed with the state of New Jersey this month.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback